Balancing Blood Sugar: Understanding and Managing Diabetes Mellitus

Diabetes mellitus is a chronic condition where the body either does not produce enough insulin or fails to use insulin effectively, leading to elevated blood glucose levels. Insulin, a hormone produced by the pancreas, is essential for regulating blood sugar by allowing cells to absorb glucose for energy. In type 2 diabetes, the body’s cells become resistant to insulin, causing sugar to accumulate in the bloodstream because cells cannot utilize it efficiently. This condition is exacerbated by factors such as obesity, sedentary lifestyle, and genetic predisposition.

Conversely, excessive insulin can result in hypoglycemia, where too much glucose enters the cells, leaving insufficient glucose in the bloodstream. This can occur due to an overdose of insulin or other medications that increase insulin levels, excessive alcohol consumption, or missed meals. When blood glucose levels drop too low, it triggers symptoms like nervousness, irritability, hunger, headache, shakiness, rapid heartbeat, and weakness. These symptoms reflect the brain's urgent need for glucose, as it relies on it as a primary energy source.

Effective management of diabetes involves maintaining blood glucose levels within a target range through a balanced diet, regular physical activity, medication, and regular monitoring. Advances in continuous glucose monitoring (CGM) and insulin pump technologies have significantly improved diabetes management, allowing for better control and reducing the risk of complications such as cardiovascular diseases, neuropathy, and retinopathy. Regular consultations with healthcare providers are crucial to tailor treatment plans and ensure optimal health outcomes for individuals with diabetes.
Balancing Blood Sugar: Understanding and Managing Diabetes Mellitus

Postabsorptive/Fasting hypoglycemia

Two types of hypoglycemia can occur in people who do not have diabetes:
• Reactive hypoglycemia, also called Postprandial hypoglycemia, occurs within 4 hours after meals.
• Fasting hypoglycemia, also called postabsorptive hypoglycemia, is often related to an underlying disease.

This classification was based on the assumption that fasting hypoglycemia is caused by organic pathologies presenting mostly with neuroglycopenic symptoms and reactive hypoglycemia arises from functional disorder presenting mostly with autonomic features.

Fasting hypoglycemia is defined as the inability to maintain glucose homeostasis in the postabsorptive, or fasting, state: An example is an insulinoma, an insulin secreting tumor of the islets of Langerhans.

Postabsorptive hypoglycemia occurs when both glucagon and epinephrine are deficient, but not when either glucagon or epinephrine alone is deficient, and insulin is present.

Fasting hypoglycemia occurring several (>5 h) hours after food, e.g., on waking or at night, or precipitated by prolonged fasting or exercise in the postabsorptive period.

Symptoms of both reactive and fasting hypoglycemia are similar to diabetes-related hypoglycemia. Symptoms may include hunger, sweating, shakiness, dizziness, light-headedness, sleepiness, confusion, difficulty speaking, anxiety, and weakness.

Causes of fasting hypoglycemia include certain medications, alcoholic beverages, critical illnesses, hormonal deficiencies, some kinds of tumors, and certain conditions occurring in infancy and childhood.
Postabsorptive/Fasting hypoglycemia

Pseudo-hypoglycemia

Hypoglycemia generally is defined as a blood glucose level of 3.9 mmol/L or lower. In patients without diabetes, hypoglycemia is a clinical syndrome with diverse causes in which low plasma glucose concentrations lead to symptoms and signs, which resolve when the plasma glucose concentration is raised.

Pseudo-hypoglycemia sometimes referred to as relative hypoglycemia, false hypoglycemia, false low. It is an event when a person experiences typical symptoms of hypoglycemia but with a measured plasma glucose concentration above 3.9 mmol/L. False hypoglycemia is having the symptoms of hypoglycemia when the blood glucose levels are in normal range or even above normal range. False hypoglycemia may occur in people with newly diagnosed diabetes whose blood glucose was significantly above normal, and is now lower

Many such patients are thought to have stress or anxiety as a predisposing factor. They may have enhanced catecholamine release following a meal, or they may be abnormally sensitive to normal postprandial calecholamine release.

This is common in patients with long-standing poor glycemic control when their plasma glucose concentration starts trending toward the normal range.
Pseudo-hypoglycemia

Iatrogenic hypoglycemia

Glycemic control is fundamental to the management of diabetes and maintenance of health. It is to avoid the complications of diabetes linked to hyperglycemia.

The most frequent complication is iatrogenic hypoglycemia that is often associated with autonomic and neuroglycopenic symptoms. Furthermore, hypoglycemia causes acute cardiovascular effects, which may explain some of the typical symptoms: ischemia, QT prolongation, and arrhythmia.

Studies have identified advanced age, malnutrition, active cancer, end-stage renal disease, liver disease, congestive heart failure, and other patient factors as contributors to hypoglycemia risk.

The use of oral agents, failure to adjust diabetes regimens in response to decreases in oral intake, and unexpected deviation from normal hospital routines have been some of the most common iatrogenic factors contributing to hypoglycemia.

Iatrogenic hypoglycemia (IH) involves reduced motivation and compliance with achieving good glycemic control that minimizes the risk of diabetic complications, with a consequent increase in cardiovascular (CV) and neurological morbidities.

Clinicians have recognized the problem of iatrogenic hypoglycemia since the first use of insulin in 1922.

Classically, hypoglycemia is defined by the Whipple triad: the presence of low blood sugar; autonomic and neuroglycopenic symptoms; and reversal of the symptoms after restoration of the blood glucose level to normal.

Iatrogenic hypoglycemia
*Causes recurrent morbidity in most people with type 1 diabetes and many with advanced type 2 diabetes and is sometimes fatal,
*Compromises physiological and behavioral defenses against subsequent falling plasma glucose concentrations and thus causes a vicious cycle of recurrent hypoglycemia, and
*Precludes maintenance of euglycemia over a lifetime of diabetes and therefore full realization of the vascular benefits of glycemic control.

Iatrogenic hypoglycemia often has a profound impact on the lives of people with diabetes (as well as on their physiological defenses against subsequent hypoglycemia).

The experience of an episode can range from unrecognized to extremely uncomfortable and disrupting. As a group, people with diabetes fear hypoglycemia more than they fear the long-term complications of diabetes.
Iatrogenic hypoglycemia

Hypoglycemia and related to diabetes

Hypoglycemia is the leading limiting factor in the glycemic management of type 1 and type 2 diabetes. Severe hypoglycemia can have potentially serious consequences for patients with diabetes, especially if it causes falls or other injuries.

Hypoglycemia happened may due to too little food or skipping a meal; too much insulin or diabetes pills; more active than usual.

Iatrogenic hypoglycemia in patients with diabetes can be defined as all episodes of an abnormally low plasma glucose concentration that expose the individual to potential harm.

Symptoms of hypoglycemia including:
Shaky, fast heartbeat, sweeting, dizzy, anxious, hungry, blurry vision, weakness or fatigue, headache or irritable.

Classification of hypoglycemia in diabetes:
* Severe hypoglycemia
* Documented symptomatic hypoglycemia
* Asymptomatic hypoglycemia
* Probable symptomatic hypoglycemia
* Pseudo-hypoglycemia

Hypoglycemic episodes are common in type 1 diabetes, and 30% of individuals with type 1 diabetes mellitus experience 1 to 3 episodes of severe hypoglycemia annually. The prevalence of hypoglycemia is three times lower in type 2 than in type 1 diabetes mellitus.
Hypoglycemia and related to diabetes

Notes

Iatrogenic: relating to illness caused by medical examination or treatment.

Blood sugar

Blood sugar is the level of glucose in the blood. Red blood cells an most of the nervous system, including the brain, rely on this fuel to meet most of their energy requirements. The body strives to maintain blood sugar at a constant level.

The liver maintains a relatively constant level of blood sugar. After a meal, blood sugar rises and then returns to normal within two to three hours, as insulin allows the body’s cells to utilize it.

When low blood sugar occurs in response to food, it’s called reactive hypoglycemia. A drop in blood sugar to a subnormal level triggers the release of hormones which counteract the hypoglycemia. The pancreas releases the hormone glucagon, the pituitary releases the adrenocor- ticotropic hormone (ACTH) and the growth hormone and the cores (medullas) of the adrenals release adrenalin.

High-sugar, junk-food diets definitely lead to poor blood sugar regulation, obesity, and ultimately type 2 diabetes. But the stress on the body that they cause, including secreting too much insulin, can also promote the growth of cancer and increase the risk of heart disease.
Blood sugar

What are the signs and symptoms of hypoglycemia?

Hypoglycemia is defined as a triad of
*Plasma glucose < 45-50 mg/dL
*Neuroglycopenia and/or hyperadrenegic symptoms
*Resolution of symptoms on administration of glucose

It is common in diabetics and the limiting factor in the management of diabetes both conceptually and in practice.

Signs and symptoms of hypoglycemia result from neuronal glucose deprivation and can be divided into two categories: autonomic and neuroglycopenic. The automatic responses of failing plasma glucose concentrations are sensitive indicators of hypoglycemia.

Epinephrine release from the adrenal medulla causes tachycardia, pallor, anxiety and tremulousness by stimulating β-adrenergic receptors. Sweating is a prominent of symptom of hypoglycemia and probably has a cholinergic cause.

Neurologic symptoms, such as confusion, lightheadedness, headache, aberrant behavior, blurred vision, loss of conciseness or seizure, are called neuroglycopenic symptoms if they are relieved by food ingestion or the administration of glucose. Because glucose is the main fuel of metabolism in brain tissue, reduced levels of glucose may insufficient to supply the brain with it energy requirements.

Such symptoms, especially if recurrent are more specific and indicate a pathologic cause of hypoglycemia.

Hypoglycemia may be difficult to notice and may occur more frequently in a person with diabetes who has been using insulin for a few years.

These could be because the two main counterregulatory system do not function after a 1 to 5 year duration of insulin dependency.
What are the signs and symptoms of hypoglycemia?